The WHO has announced Secorin, the fourth human papillomavirus (HPV) vaccine product prequalified by the WHO.® It has been confirmed for use in a single-dose schedule....
Despite “remarkable advances” in cancer research and treatment, cancer remains a “persistent public health challenge” that requires significant attention and funding, it said. Cancer Progression Report...
In a recently published study, Frontiers in Cellular and Infectious MicrobiologyA group of researchers investigated the association between high-risk (HR) and low-risk (LR) human papillomavirus (HPV)...
Nova Scotia plans to follow other provinces in testing for cervical cancer, but the switch from Pap smears to HPV tests is at least two years...
Implementing human papillomavirus (HPV) testing in British Columbia could help eliminate cervical cancer in the province by 2040, a Canadian modelling study has found. CMJ (Canadian...
New research shows that the HPV vaccine protects against cancer in men as well as women, yet fewer boys than girls in the United States are...
Recent Comments